Adhesives and sealants in medicine, dentistry and pharmacy - a review of materials and applications - Part II
TWI Bulletin, March/April 2002
Mehdi Tavakoli received a BSc in Chemistry and an MSc and PhD on Polymer Science and Technology at Aston University in Birmingham. He joined TWI in 1989 and has been working on new joining and associated technologies with particular interest in joining and coating of medical and implantable devices. He has over 20 years research, industrial problem solving and product development experience on polymeric materials and has published more than 40 papers and patents and is currently working as Technology Manager on polymers/adhesives at TWI.
The first episode of Mehdi Tavakoli's review of materials and applications in adhesives and sealant in medicine dealt with joining tissue, muscle and bone. Part two continues the story with examination of TWI's work on dental and pharmaceutical adhesives.
Adhesives and adhesion in dentistry have been recognised as important materials and issues for dentistry for many years.
[23-24] Significant advances have been made to develop dental adhesives and polymeric compositions with improved adhesion and durability. Polymeric resins and adhesives are being used for filling cavities, to bond other materials to tooth, to enhance the appearance of a tooth or as a protective layer on vulnerable tooth surfaces.
The areas of tooth which will be in contact with the adhesives are enamel or the underlying dentine. The main structure of tooth is based on dentine which consists of 69% calcium hydroxyapatite, 18% collagen and water. Dentine is covered with enamel which consists of 96% hydroxyapatite.
The main critical issues which affect the performance of dental adhesives are similar to the main factors affecting non-dental bonding applications:
- Reactivity of adhesives - includes chemical ( eg primary and secondary chemical bonding) and physical (wetting, penetration into surface irregularities) reactivities between the adhesive and the tooth ( eg dentine and enamel) surfaces.
- Surface condition of tooth - chemical and physical surface conditions of the enamel and dentine can affect adhesion of dental material and long-term durability. The presence of surface contamination, such as debris (generated as a result of drilling and cutting operations), saliva or wear surface layers ( eg incomplete removal of caries) can lead to a weak interface between the dental material and tooth. This can lead to penetration of moisture and fluids to the interfacial regions and premature failure of restorative or decorative materials.
- Mismatch of thermal or fluid expansion properties between dental materials and tooth can cause residual stress which can lead to premature failure.
- Shrinkage of adhesives during or after the curing reactions can cause disbonding and premature failure.
- Insufficient cure - lack of complete cure or setting of the polymeric resins can cause formation of a weak protective or filling material which will be susceptible to premature degradation and failure. Nowadays almost all adhesives in restorative dentistry are based on visible light-curing polymeric resins. Incomplete curing of these material ( eg due to short cure times, insufficient radiation energy or shadowing effect in thick section fillings) can produce fillings with low cohesive strength, low adhesion which are prone to microcracking, debonding and deterioration.
Polymeric adhesives and composites used in dentistry are generally based on combinations of acrylate/bioacrylate or methacrylate multifunctional monomers, activators, adhesion promoters and fillers. Curing and polymerisation of these resins take place through a free radical chain mechanism in the presence of initiators. Typical initiators or activators used in these formulations include redox systems ( ie a reducing agent ( eg an aromatic amine) and an oxidising agent place throug peroxides, such as BPO) or a photo-initiator for light curing polymerisation. New generations of dental adhesives can provide high bond strength (15-25MPa) to dentine or enamel. Recently the use of photochemically ( eg use of blue light, l = 470nm) activated dental adhesives has considerably replaced the chemically activated systems. Avoiding oxygen inhibition of the curing process, improving mechanical properties and long term durability, and better adhesion to various surfaces of dental adhesives are still areas of research.
Development of a new type of high impact strength dental polymeric resins has been achieved by using reinforcing effects of acrylic-terminated butadiene-styrene block copolymers for modification of polymethylmethacrylate polymers.
Another important class of materials is based on glass ionomer systems. These are used as an aesthetic restorative filling and as core build up materials in dentistry. The main components of these conventional cements are: [25]
- Fluoroaluminosilicate (FAS) glass powder
- Ionic poly mer which is a polycarboxylic acid
- Tartaric acid
- Water
These are formulated to provide a powder and a liquid portion which are mixed under a chemical reaction to provide a set cement. The original glass ionomer suffered from a number of disadvantages: brittleness and susceptibility to early moisture contamination, short working time and long set time. These disadvantages led to the development of light curing glass ionomer cements for dentistry. The curing reactions of light cure glass ionomers are shown in Fig.7.
Fig.7. Setting reactions of Vitrebond light-cured glass ionomer [25]
Two types of reaction take place:
- The acid groups of the polymer attack the FAS glass releasing positively charged ions. These ions react with the carboxylic acid groups of the polymer in an acid-base curing reaction. A very important by-product of this curing reaction is the sustained release of fluoride ions which are known to provide caries resistance and prevent tooth decay. The acid-base reaction can continue indefinitely and therefore the release of fluoride also continues for prolonged periods in a consistent manner.
- A light activated free radical polymerisation of methacrylate groups of the polymer and HEMA (2-hydroxyethylmethacrylate). The rate of this reaction is much faster than the first set of reactions.
However, light curing glass-ionomers also suffer from limitations in depth of cure, which means that time-consuming and complicated layer by layer curing is required when thicker sections are used. This led to the development of a new generation of Vitremer tri-cure glass ionomer systems. [25] Vitremer can, under a third mode of cure, ensure complete setting in deeper sections and shadowed areas. The Vitremer tri-cure system is shown in Fig.8.
Fig.8. Setting reaction of Vitremer tri-cure glass ionomer [25]
The third reaction is a dark cure of the methacrylate groups of the polymer systems and HEMA. The relatively fast cure is initiated by a water-activated redox catalyst [26] which enables the methacrylate cure to occur in the dark. This is a unique feature of Vitremer tri-cure based materials producing uniform cure throughout the glass ionomer restoratives, resulting in enhanced physical properties even in thick sections.
Another area of adhesives use in dentistry is for fixing dentures. There are a wide range of denture adhesives which are available commercially. [27] Typical examples are shown in Table 4. Denture adhesives are available in the form of liquids, creams and powders and the active ingredients of many of them are based on one or more of the following constituents:
- Gum karaya
- Polyethylene oxide
- Sodium carboxymethyl cellulose
- Sodium alginate
However, in spite of the wide availability of denture adhesives their use is still limited due to concern over their possible adverse effects on oral tissues.
| Table 4: Typical examples of commercially available denture adhesives [27] |
| Brand name | Active constituents | Manufacturer |
| Liquid adhesives |
| Corega | Mineral oil, CMC, polyethylene oxide | Stafford-Miller Ltd, Ireland |
| Steradent | Paraffin oil, socium alginate, carbomer, CMC, polyethylene glycol | Reckitt & Colman, France |
| Cream adhesives |
| Calox | Mineral oil, CMC, Gantrez | Glaxo SmithKline Beecham, The Netherlands |
| Protefix Haft-Creme | Not communicated | Queisser Pharma, Germany |
| Super Poli-Grip | CMC, polyethylene oxide | |
| Corega Cream | CMC, Gantrez | |
| Powder adhesives |
| Corega | Gum karaya, polyethylene oxide | |
| Corega Super | CMC, polyethylene oxide | |
| Dentofix | Gum karaya | J Hilgers, Germany |
| Dentofix Forte | Pectin, gelatin, CMC | J Hilgers, Germany |
Dentofix Extra Forte | Gelatin, CMC, sodium alginate | J Hilgers, Germany |
Enzyparadon Adhesive | Gum karaya | Le Marinel, Belgium |
| Fixeco | Gum karaya | Sanibel, Belgium |
| Fixobel Forte | Gum karaya | Qualiphar, Belgium |
| Palafix | Gum karaya | Sanibel, Belgium |
| Protefix | Sodium alginate | Queisser Pharma, Germany |
| Steradent Fixative | CMC | Kukident, Germany |
CMC - sodium carobxymethyl cellulose. Gantrez - double salt (calcium and sodium) of poly(vinylmethyl ether)/maleic anhydride copolymer |
Pharmaceutical polymers and adhesives
Many polymers are being successfully used in pharmaceutical applications including drug delivery systems
[28] such as capsules, coatings etc. To be successfully used in drug delivery systems, a polymer has to have the following characteristics:
- Pharmaceutical grade
- Unable to produce extractable species
- Chemically inert
- Easily processable
- Suffer minimal undesirable ageing
The important types of polymers being considered or used in drug delivery systems include:
[28] - Polyethylene glycol
- Polyacrylic acid
- Polyvinyl alcohol
- Polymethacrylic acid
- Polyacrylamide
- Poly N-vinyl-pyrrolidone
There are other relevant polymers specifically designed to degrade within the body such as:
- Polyorthoesters
- Polylactides
- Polyglicolides
- Polyanhydrides
As a result of biodegradation these polymers are broken down into biologically acceptable molecules that are metabolised and removed from the body via normal metabolic pathways.
One of the most important classes of synthetic polymers used in pharmaceutical applications is based on acrylic resin systems. [29-30] Specific grades of acrylic polymers have been used, or considered for use, in many pharmaceutical applications such as drug delivery systems, as a container to deliver drugs or as coatings. These applications include gastro-intestinal, epidermal, transdermal, nasal, ocular drug delivery systems or as hydrogels. These polymers are primarily based on acrylic acids, methacrylic esters or acrylic resins. The chemical structure and composition of the most commonly known grades are shown in Tables 5 and 6. [29]
Table 5: Chemical structure of (meth)acrylic monomers, general formula: CH 2=C(R 1)-CO-(R 2) [29] |
| Monomers | R 1 | R 2 | Chemical name |
| AA | H | OH | Acrylic acid |
| AAm | H | NH 2 | Acrylamide |
| BCA | CN | O-C 4H 9 | Butylcyanoacrylate |
| BMA | CH 3 | O-C 4H 9 | Butyl methacrylate |
| DEAEMA | CH 3 | O-CH 2-CH 2-N(C 2H 2) 2 | N,N-diethyl aminoethyl methacrylate |
| DHPMA | CH 3 | O-CH 2-CHOH-CH 2-OH | Dihydroxypropyl-methacrylate |
| DMAEMA | CH 3 | O-CH 2-CH 2-N(CH 3) 2 | N,N-dimethylaminoethyl-methacrylate |
| EA | H | O-CH qH 5 | Ethylacrylate |
| ECA | CN | O-CH qH 5 | Ethyl cyanoacrylate |
| EGDMA | CH 3 | O-CH 2-CH 2-O-CO-C(CH 3)=CH 2 | Ethylene glycol dimethacrylate |
| HECA | CN | O-CH 2-CH 2-OH | Hydroxyethyl cyanoacrylate |
| HEEMA | CH 3 | O-CH 2-CH 2-O-CH 2-CH 2-OH | Hydroxyehtoxyethyl methacrylate |
| HEMA | CH 3 | O-CH 2-CH 2-OH | Hydroxyethyl methacrylate |
| HPMAm | CH 3 | NH-CH 2-CH-OH-CH 3 | N-( 2-hydroxypropyl) methacrylamide |
| IBCA | CN | O-CH 2-CH 2-(CH 2) 2 | Isobutyl cyanoacrylate |
| IPAAm | H | NH-CH 2-(CH 2) 2 | N-isopropyl acrylamide |
| MA | CH 3 | OH | Methacrylic acid |
| MeA | H | O-CH 3 | Methylacrylate |
| MMA | CH 3 | O-CH 3 | Methyl methacrylate |
| TAMCI | CH 3 | O-CH 2-CH 2-N(CH 3) 3CI | Trimethyl ammonioethyl methacrylate chloride |
| Table 6: Composition, monographs, abbreviated and brand names [29] |
| Poly- | Weight ratio | Monograph | Brand name |
| AA | | Carbomer HF/USP | Carbopol |
| BMA/MMA/DEAEMA | 1/1/2 | Aminoalkyl methacrylate copolymer EJPE/DAB | Eudragit E100 |
| EA/MMA | 2/1 | Polyacrylate dispersion 30% EP | Eudragit NE30D |
| EA/MMA/TAMCI | 1/2/0.2 | Ammionioethyl methacrylate copolymers, type A, NF/USP | Eudragit RL100 |
| EA/MMA/TAMCI | 1/2/0.1 | Ammionioethyl methacrylate copolymers, type B, NF/USP | Eudragit RS100 |
| MA/EA | 1/1 | Methacrylic acid copolymers, type C, NF/USP | Eudragit L100-55 |
| MA/MMA | 1/1 | Methacrylic acid copolymers, type A, NF/USP | Eudragit L100 |
| MA/MMA | 1/2 | Methacrylic acid copolymers, type C, NF/USP | Eudragit S100 |
| MeA/MMA/MA | 1/1/0.2 | New | Eudragit prep 4110D |
Work carried out at TWI has shown that welding and adhesive bonding can be used effectively for joining and sealing pharmaceutical polymers.
Typical examples of pH dependent commercially available acrylic polymers are shown in Table 7. These polymers are designed to be activated in different pH environments of the gastro intestinal system, see Fig.9.
| Table 7: Typical examples of commercially available methacrylic based polymers (Eudragit ®) used in pharmaceutical applications [30] |
| Type | Application | Solubility permeability | Tradename |
| Eudragit RL | Sustained-release formulations, rapidly disintegrating coatings, sustained-release formulations, pH-independent | pH independent Readily permeable | Eudragit RL100 Eudragit RLPO Eudragit RL30D |
| Eudragit RS | Sustained-release formulation, pH-independent | pH independent Poorly permeable | Eudragit RS100 Eudragit RS100 Eudragit RS PO Eudragit RS30D |
| Eudragit NE | Sustained-release formulations, pH-independent, matrix structures | pH independent Expandable, permeable | Eudragit NE30D Eudragit NE40D |
| Eudragit E | Rapidly disintegrating coatings, pH dependent, taste and odour masking, coloured or transparent, against abrasion and dust formation | Soluble in gastric juice up to pH 5.0 | Eudragit E100 Eudragit EPO Eudragit RD-100 |
| Eudragit L | Enteric coatings, coatings resistant to tropical conditions, lozenges, sealing coats | Soluble in intestinal pH 5.5 and above Soluble in intestinal above pH 6.0 | Eudragit L30D-55 Eudragit L100-55 Eudragit L100 |
| Eudragit S | Enteric coatings, sustained-release formulations, pH-dependent | Soluble in intestinal pH 7.0 and above | Eudragit S100 |
| Table 8: Plasticisers used in methacrylic coatings and their solubility in water [30] |
| Plasticiser | Solubility in water at room temperature, % |
| Triethyl citrate | 6.9 |
| Acetyl triethyl citrate | 0.72 |
| Tributyl citrate | <0.002 |
| Acetyl tributyl citrate | <0.002 |
| Triacetine | 7.1 |
| Diethyl phthalate | 0.15 |
| Diethyl phthalate | 0.04 |
| Polyethylene glycol 6000 | >30 |
| Polysorbate 80 | >30 |
Fig.9. Gastro intestinal system
Concluding remarks
Polymeric materials are used in a variety of applications in medicine including surgery, pharmacy and dentistry. Many new materials, processing and applications techniques are being developed to overcome disadvantages associated with current systems. Novel natural and synthetic polymers can be formulated with specific and exact properties to satisfy challenging applications in medicine and dentistry. New biodegradable polymers (
eg tissue adhesives and pharmaceutical polymers) which can break down into non-toxic, low molecular weight species (after providing the required function), in a physiological environment such as in contact with tissue or the gastro intestinal system, are being developed. This is also true for the new generation of polymers which are required to have resistance to biodegradation when used as part of permanent or semi-permanent implants.
It should be noted that many critical issues for the use of adhesives and polymers in medicine, dentistry and pharmacy are also of significant importance to adhesion scientists and technologists. For example, the surface characteristics of the skin (eg wet, dry, soft or fragile) or surface condition of a tooth is as critical as in tissue bonding or dentistry as the surface properties of metallic or non-metallic adherends used in non-medical ( eg automotive and aerospace) bonding applications. Surface pretreatments and the use of primers and adhesion promoters can also play a major role in both of these cases. Other major issues which are shared by some of the medical and non-medical uses of polymers include mechanisms of adhesion, the nature and strength of interfaces, mechanisms of biodegradation as well as the nature of degradation products.
Many other factors relevant to medical use of adhesives and bone cements can also be related to non-medical applications, for example; low exothermic polymerisation reactions, purity of the polymeric resins, low or non release of monomers or other volatiles during or after cure, good mechanical properties, low shrinkage and low creep, rapid cure after dispensing and improved adhesion. These plus a level of durability and reliability are of critical importance to opto and micro-electronic use of adhesives.
It is believed that a multi-disciplinary approach and utilisation of relevant issues from non-medical use of polymers, adhesives, sealants or coatings can significantly improve progress in medical applications of polymers. Many common issues relevant to materials development, joining techniques, degradation mechanisms and surface and interface assessment techniques can be successfully utilised from industrial applications to the medical sector.
Based on these facts TWI is actively working with clinicians, hospitals and well known biomaterials groups to study some of the most fundamental issues related to these areas.
Acknowledgements
The author wishes to thank Henkel/Loctite UK, 3M UK, Chemence and Degussa UK for providing some of the photographs and information.
Adhesives and sealants in medicine, dentistry and pharmacy - a review of materials and applications - Part I of this report.
References
| N° | Author | Title | |
| 1 | Tavakoli S M: | 'The adhesive bonding of medical devices'. Medical Device & Diagnostic Industry June 2001 58-73. | |
| 2 | Tavakoli S M: | 'Sticking to the healthy option - using adhesive bonding in medical and implantable devices - part 1'. TWI Bulletin 2001 42 (3) 35-37. | |
| 3 | Tavakoli S M: | 'Sticking to the healthy option - using adhesive bonding in medical and implantable devices - part 2'. TWI Bulletin 2001 42 (4) 65-68. | |
| 4 | Frye A: | 'Can you really use super glue instead of suture?' www.fensende.com/users/swnymph/refs/glue.html | |
| 5 | Alan C R: | 'Medical adhesives'. Adhesive Technology 4 June 1998. | |
| 6 | Kenney J F et al: | 'Medical-grade acrylic adhesives for skin contact'. Journal of Applied Polymer Science 1992 45 355-361. | |
| 7 | Webster I: | 'The development of a pressure sensitive adhesive for trauma-free removal'. International Journal of Adhesion and Adhesives 1999 19 29-34. | |
| 8 | Webster I: | International patent WO 99/18136, 15.04.99. | |
| 9 |
| Indermil: Tissue adhesive, a translucent medical adhesive for closing wounds and lacerations. Technical Data Sheet, Loctite/Henkel Corporation. | |
| 10 | Kao F J and Manivannan G: | 'Copolymers of N-vinyl pyrrolidone'. Journal of Biomedical Materials Reviews, 1997 38 (3) 191-196. | |
| 11 | Glaskin M: | 'Surgeons with sticking power'. The Sunday Times 9 April 2000. | |
| 12 | Kotzev D L: | Bio-adsorbable cyanoacrylate adhesives. US Patent 6224622 May 1 2001. | |
| 13 | Sierra D and Saltz R: | 'Surgical adhesives and sealants current technology and applications'. Technomic Publishing Company 1996. | |
| 14 | Rahman F F: | 'Biocements for the joining of bone'. Report submitted for the Certificate of Postgraduate Study at the University of Cambridge. | |
| 15 | Hardinge K: | 'Hip replacements, the facts'. Oxford University Press 1983. | |
| 16 | Weightman B et al: | 'The mechanical properties of cement and loosening of the femoral component of hip replacements'. J Bone and Joint Surgery 1987 69 558 564. | |
| 17 | Harper E J: | 'Development and characterisation of a hydroxyapatite reinforced poly (ethylmethacrylate) bone cement'. PhD Thesis, University of London, 1996. | |
| 18 | Cameron H U: | 'Smooth metal-bone interface'. R Hurley (ed) Bone Implant Interface, St Louis Mosby 1994 a 121-144. | |
| 19 | Park S H et al: | 'Hard tissue replacements'. Bronzino J D (ed) The Biomedical Engineering Handbook CRC Press 1995 672-690. | |
| 20 | Cameron H U: | 'The implant-bone interface porous materials'. R Hurley (ed) Bone Implant Interface St Louis Mosby 1994 b 145-168. | |
| 21 | Morscher E W: | 'Current status of acetabular fixation in primary total hip arthoplasty'. Clin Orthop 274:172 1992. | |
| 22 | Malchau H, Herberts P and Ahnfelt L: | 'Progression of total hip replacement in Sweden'. Acta Orthop Scand 1993 64 497-506. | |
| 23 | Jones S E B: | 'The story of adhesion and developments in dentistry'. International Journal of Adhesion and Adhesives 1995 15 109-113. | |
| 24 | Ali S A M, Jaworzyn J and Williams D F: | 'On the mechanisms of dentine coupling agents'. Journal Adhesion Science and Technology 1990 4 79-87. | |
| 25 | 3M Vitremer: | 'Tri-cure glass ionomer system'. Technical product profile published by 3M, publication no Rev.1-12/92, 1992). | |
| 26 | | US Patent 5154,762. | Return to text |
| 27 | Collys K D, Roma de Sousa A C and Smeyers-Verbeke J: | 'Soluble denture adhesives: pH and sodium content'. Europea J Prosbedont Rest Dent 1997 5 63-67. | |
| 28 | Peppas L B: | 'Polymers in controlled drug delivery'. Journal of Medical Plastics and Biomaterials November 1997 34-46. | |
| 29 | Dittgen M, Durrani M and Lehmann K: | 'Acrylic polymers, a review of pharmaceutical applications'. S T P Pharma Sciences 1997 7 (6) 403-437. | |